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Endovascular cerebral aneurysm treatment: Long-term 
outcomes
David E Le Feuvre, Allan G Taylor
Endovascular treatment has been confirmed as the treatment 
of choice for intracranial berry aneurysms.1 While initial 
doubts on the part of microvascular neurosurgeons were 
addressed by the International Subarachnoid Aneurysm trials, 
the durability and long-term efficacy of coiled aneurysms 
have been questioned.1 A reason for this is the morphology 
that may be evident in coiled aneurysms on angiographic 
follow-up. Comment on the significance of the morphological 
angiographic picture requires adequate follow-up, which 
means that institutions treating aneurysms need to audit 
their results so that larger numbers can provide a clearer 
understanding. Following up patients angiographically 
may also clarify the natural history of neck remnants. The 
idea that an aneurysm needs to be treated so as to give a 
perfect radiological picture may not necessarily be true. We 
investigated the impact of our treatment of subarachnoid 
haemorrhage and showed that after the introduction of 
endovascular treatment the time to treat patients was reduced 
and consequently the rebleeding rate dropped.2 We now 
needed to establish that these benefits were sustainable.
Methods
Although we have been using endovascular treatment for 
aneurysms since 2000, for this study we looked at patients 
treated between 2002 and 2003 because we had sufficient 
numbers and long enough follow-up (between 3 and 4 
years). Our technical skills had improved and were closer 
to the standard in other institutions. All aneurysms treated 
endovascularly from February 2002 to February 2003 were 
analysed using procedure records and angiographic pictures. 
Our routine is to do follow-up angiograms after the initial 
procedure and at 3 months, 1 year and 5 years, provided there 
are no problems concerning treatment or stability of the coiled 
aneurysm. Should there be grounds for concern the angiograms 
are repeated as often as required. If the 3-month follow-up 
necessitated recoiling, the angiogram would be repeated 1 
month after the procedure. We compared our percentage of 
aneurysms successfully coiled at the initial procedure with 
the 3-month and 1-year follow-up angiographic findings. 
We were particularly interested in seeing what happened to 
residual neck remnants, which were graded according to the 
classification of Roy et al.3 as more than 90% if there was more 
than just neck filling (such as the aneurysm still filling), 91 - 
99% if there was no aneurysm filling but neck filling, and 100% 
for a complete result. We intended to determine how many 
remnants were stable, how many deteriorated, and whether 
some improved. Patients were contacted to assess their 
wellbeing and to find out how many were back at work. 
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Introduction. The International Subarachnoid Aneurysm Trial 
confirmed endovascular treatment as the treatment of choice 
for intracranial ‘berry’ aneurysms. The durability of coiling 
and the relevance of stable neck remnants needed to be 
addressed next. 
Methods. We retrospectively assessed the follow-up 
angiograms of patients who presented with subarachnoid 
haemorrhages or third-nerve palsies and had berry 
aneurysms treated endovascularly between 2002 and 2003. 
Patients were phoned to assess their wellbeing and to see 
whether they were back at work or not.
Angiograms were assessed to ascertain the percentage of 
the aneurysm coiled at the initial procedure, and then stability 
was assessed by percentage change in the residual aneuysm 
neck on later angiograms.
Results. Over a 1-year period 75 patients were treated 
endovascularly; 100% occlusion was achieved in 52% at the 
initial procedure, and although only 40 and 34 respectively 
attended for 3-month and 1-year follow-up angiograms there 
was a trend toward progressive thrombosis in 65% and 82% 
respectively. In only 1 of the neck remnants was growth noted 
at the 3-month angiogram. One patient bled after missing 
his 3-month follow-up angiogram. Although only 40% of the 
patients were contactable at 4 years there were no rebleeds 
among them.
Conclusion. Coiling is durable, as shown by our results over a 
4-year period, and while neck remnants that look unchanged 
are generally stable any growth should be viewed as grounds 
for concern and treated either endovascularly or surgically if 
required. The 5-year angiogram may be unnecessary, which 
is of importance in our setting where socio-economic factors 
influence patient follow-up. 
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Results
During the period 2002 - 2003 we treated 75 patients. There 
were 84 procedures done (Table I).
The aneurysms we treat tend to be small sacular aneurysms, 
the vast majority measuring between 2 mm and 6 mm. We try 
to avoid remodelling, but used stents in 5 cases and balloons 
in 2. In 9 cases we failed to coil the aneurysm. The reasons for 
failure included difficult access, unfavourable neck-to-dome 
ratios or wide necks, and aneurysms that were too small or 
were thought to look like dissections rather than typical ‘berry 
aneurysms’. One patient rebled and died the night before her 
procedure, and another died while her aneurysm was being 
treated with Onyx, which we no longer use to treat aneurysms.
The results of coiling at the end of the first procedure are 
shown in Table II.
Of the patients, 40 (approximately two-thirds of available 
patients) had 3-month follow-up angiograms. At 3 months 6 
patients had a further procedure, but in only 2 cases was it 
necessary to recoil an aneurysm. In the other 4 patients another 
aneurysm was treated (Table III).
Twelve patients showed progressive thrombosis of their 
aneurysms, so further intervention was not deemed necessary; 
6 patients had residual necks that were thought to be stable 
compared with their original angiographic picture, and 3 
patients developed more residual filling of the aneurysm, in 2 
cases to less than 90% so the aneurysm had to be recoiled. One 
patient died of leukaemia before he could be retreated, and one 
patient, who had less than 90% occlusion at initial treatment, 
was found to have had progressive occlusion of the aneurysm. 
After the 3-month angiogram 4 further patients died from 
unrelated medical problems.
One-year follow-up angiograms were done on 34 patients 
out of a possible 58 (59% of the patients who could have been 
followed up) (Table IV).
Two patients had further occlusion to 100%. In 5 patients the 
remnant remained stable and in one patient a remnant that had 
increased in size to <90% required recoiling. One patient had 
been referred to us from another unit where an attempt to clip 
a posterior communicating artery aneurysm had failed as the 
neck was heavily calcified. We were able to coil the aneurysm 
and achieved occlusion of >95% on initial coiling. The patient 
defaulted from follow-up and missed his 3-month angiogram 
but re-presented having re-bled as a World Federation of 
Neurosurgeons (WFNS) grade 1. His angiogram revealed coil 
compaction with <90% occlusion. The aneurysm was coiled 
again with close to complete occlusion. A 3-month follow-up 
angiogram showed a stable result. 
Another patient had neck growth rather than coil 
compaction. This patient had three endovascular procedures 
that failed to treat the aneurysm satisfactorily. At each 3-month 
follow-up angiogram there was a >90% residual neck. Surgical 
clipping of this aneurysm proved extremely difficult and even 
though a clip was applied over the neck the pressure was too 
high and there was insufficient space to apply a booster clip. 
The patient rebled and died in the intensive care unit. 
At or after 4 years we were able to contact 30 patients to 
assess their wellbeing; 10 (one-third) were still working. The 
28 patients about whose wellbeing we are uncertain were 
uncontactable. 
Discussion
The Guglielmi Detachable Coil (GDC) was introduced in 1991 
with Food and Drug Administration approval in 1995.4 By 
August 2002 over 100 000 patients had been treated with GDC 
coils and the first randomised prospective study of coiling 
versus clipping confirmed the 1-year advantage of the former 
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Table I. Distribution of coiled aneurysms
Anterior choroidal     1
Anterior communicating     7
Basilar tip    11
Carotid termination      3
Intracavernous      3
Superior hypophyseal    1
Middle cerebral artery  13
Ophthalmic     2
Posterior cerebral     1
Posterior communicating  36
Pericallosal     1
Superior cerebellar      1
Vertebral      4
   Total    84
Table II. Angiographic results of coiling at end of first 
procedure
  Percentage                   Number (%)
  occlusion                   of patients
  100%       39 (52%)
  95 - 99%       24 (32%)
  <95%       12 (16%)
Table III. Angiographic results at 3 months
  Percentage                      Number (%)
  occlusion                      of patients
  100%          26 (65%)
  95 - 99%         7 (17.5%)
  <95%         7 (17.5%)
Table IV. Angiographic results at 1 year
  Percentage                Number (%)
  occlusion                of patients
  100%    28 (82%)
  95 - 99%      5 (15%)
  <95%      1 (3%)
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with regard to prevention of death and dependency. Critics 
of coiling initially silenced by the ISAT results came back 
with scepticism regarding the long-term durability of coiling.1 
Although it was not significant, the higher rebleeding rate 
in the ISAT trial was pointed out and questions were asked 
about the significance of aneurysmal neck remnants. It was 
therefore considered important to address these criticisms by 
studying the long-term follow-up of coiled aneurysms. Initially 
it was not clear what ‘long term’ represented and it was felt 
that ongoing studies might shed light on this question. In 
2006 Henkes et al. published early angiographic and clinical 
results.5 They commented on the paucity of data on long-term 
coiling results and that these series were small and may have 
been affected by uncontrolled factors and inconsistencies. 
For example, two of the articles were concerned only with 
posterior circulation or basilar tip aneurysms, which reflected 
the attitude to endovascular treatment of aneurysms.
In 1999 Byrnes et al. published their 5-year experience with 
coil embolisation for ruptured intracranial aneurysms, looking 
specifically at outcomes and incidence of late rebleeding,6 
and in 2002 Batista et al. published their 5-year angiographic 
and clinical results of coiled aneurysms.7 Despite these and 
other publications scepticism persists. In 2006 the CARAT 
Investigators commenced a study of delayed rebleeding rates 
in coiled and clipped aneurysms8 because of ‘a paucity on 
long-term outcomes’ which is a ‘major concern’. For this reason 
we also decided to study our long-term results.
Ultimately the reason for hesitancy in accepting coiling 
of aneurysms as a treatment is the concern that they will re-
bleed, which long-term follow-up will address. Microvascular 
surgeons are especially sceptical about aneurysmal neck 
remnants. Continuous and long-term follow-up will assist 
in defining how long ‘long-term’ is in following up coiled 
aneurysms. Although it is our protocol to do angiographic 
follow-up at 3 months, 1 year and 5 years, it may prove 
unnecessary to wait 5 years and that two unchanged 
consecutive stable angiograms is enough.
Our follow-up of between 54 and 60 months is better than 
Byrnes et al.’s 5-year experience of between 6 and 65 months 
(median 22.3 months) and closer to that of Batista et al., who 
had 5-year follow-up.6,7 Like us, Batista et al. found it difficult 
to follow up all the patients initially entered into their study. 
Of the 102 patients who had aneurysms coiled, 85 had 1-year 
angiographic follow-up but only 45 had 5-year follow-up.7 Of 
our possible 59 patients, 34 had 1-year angiographic follow-
up. Since at 4 years we could contact only 30 patients, 5-year 
follow-up numbers will be low, which is to be expected 
because of the socio-economic factors and our referral 
patterns. However the low number of follow-ups highlights 
the importance of establishing how durable coiling is so that 
unnecessary follow-up is avoided.
Analysis of the aneurysms coiled shows that there was 
a high percentage of internal carotid artery aneurysms. 
Just under half of the aneurysms treated were posterior 
communicating artery aneurysms, not because we selected 
them to coil but because they seem to have a high incidence 
in our population.9 The proportion of middle cerebral artery 
aneurysms that we coiled is higher than in other studies,1,5,10 
because we believe that partial coiling has a protective effect. 
As primary interventionalists, whether the aneurysm is treated 
endovascularly or surgically we have a low threshold for 
clipping an aneurysm if in doubt as to whether it can be treated 
safely. Our threshold for clipping MCA aneurysms is low.
Our initial 100% occlusion rate was 39 (52%) out of 75, 
which is within the limits of those in other studies that show 
lower (39%) and higher (63%, 88%) 100% occlusion rates.5,11,12 
When Kole et al. critically assessed their 100% occlusion 
results they found that only 16% of their patients had 100% 
while 57% had >91% occlusion.13  On the initial follow-up 
angiogram 12 (30%) of our patients had progressive thrombosis 
to complete occlusion. In other words although there was 
residual aneurysmal neck after the initial coiling, in 30% of 
patients there was progression to complete occlusion at the 3-
month angiogram follow-up. This is in keeping with findings 
elsewhere11 and translates into 65% complete occlusion at 3 
months.  
At the 3-month angiographic follow-up 6 of our patients 
had stable neck remnants. We consider neck remnants stable 
if the aneurysm is >95% treated and looks unchanged on the 
3-month follow-up angiogram. If there is any concern over 
a remnant it is either treated or followed up sooner with a 
repeat angiogram. Of our patients, 3 patients had increased 
filling of the aneurysm on the follow-up angiogram; in 2 the 
initial occlusion was not 100%, but in the third occlusion was 
judged to be 100%. This patient seemed to show neck growth 
rather than the coil compaction seen in the other 2. Despite 
three attempts at re-treatment the neck continued to grow 
and even surgical intervention failed to save the patient. We 
have become very wary of neck growth and in this situation 
have a lower threshold to proceed to clipping. Three other 
patients in our series haemorrhaged: one was transferred to 
us with a basilar tip aneurysm and bled the night she arrived 
in the intensive care unit; another had a dissection of the 
internal carotid artery while her posterior communicating 
artery aneurysm was being treated with Onyx, which we no 
longer use for aneurysms; and the third patient was referred 
to us with what had been considered an unclippable posterior 
communicating artery aneurysm, which we were able to coil 
with a satisfactory result of between 95% and 99% occlusion. 
This patient defaulted from his 3-month angiogram, re-
presented with a World Federation of Neurosurgeons grade 1 
subarachnoid haemorrhage, and had his aneurysm coiled; a 
follow-up angiogram showed a stable remnant.
We are unable to do auto-triggered elliptic-centric-ordered 
three-dimensional gadolinium-enhanced magnetic resonance 
angiograms at our hospital, but in elderly patients who have 
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had an aneurysm coiled we do more time-of-flight magnetic 
resonance angiograms, especially if happy and confident about 
our initial coiling result. We would ideally like to do more 
magnetic resonance angiograms as follow-up, since we believe 
this provides enough information on which to base a decision 
whether or not to re-treat an aneurysmal remnant.
In our previous study of the impact of endovascular 
treatment of aneurysms we found that the reduction we 
achieved in the time to treat SAH patients has reduced the 
in-patient rebleed rate.2 This is logical considering that the 
re-haemorrhage rate is highest in the first 48 hours, as was 
found in the ISAT trial.1 To treat our patients as expediently 
as possible, procedures in WFNS grade 1 or good grade 2 
patients with posterior communicating artery aneurysms are 
done under local anaesthetic; we have done this in at least 12 
cases, with good results. Unlike experience in the ISAT trial, 
we are not aware that any of our coiled patients experienced 
post-procedural haemorrhages. Our single rebleed occurred 
in a patient who had undergone both clipping and coiling, 
highlighting the fact that both treatments are susceptible to 
failure. To assess our results better we contacted as many of 
our patients as possible. Because we are a referral hospital with 
patients coming from considerable distances, and because of 
socio-economic factors, follow-up is sometimes difficult. Two 
patients who had not had 1-year follow-up angiograms refused 
to come in 3 years after coiling because they said they were 
‘fine’.
Because we are primary interventionalists and can offer 
coiling or clipping, we try to eliminate cases in which coiling 
would be a high-risk procedure and rather treat them 
operatively. This is especially true of dissections, which are 
treated surgically in the anterior circulation. This policy should 
not influence our results with regard to re-haemorrhage rates 
in coiled aneurysms; however, it will affect our re-haemorrhage 
rates in clipped aneurysms, as aneurysms that are not coilable 
tend also to be difficult to clip. 
Rates of rebleeding from coiled aneurysms are coming 
down. The CARAT investigators8 found a re-rupture rate of 
0.11% annually, which is in keeping with our findings. Porter 
et al.14 observed a de novo aneurysm formation rate of 0.76% 
per year, but others have found this to be nearer 2%. The de 
novo aneurysms could also account for ‘rebleedings’ that are 
reported to be from the coiled aneurysm but in fact are not. 
In our opinion dissections of the anterior circulation should 
not be treated with coil embolisation, and it is possible that 
endovascular treatment of these aneurysms in other series 
contributes to the rebleed rate.
New softer coils and coils with complex shapes allow better 
packing of aneurysms. Tamatani et al. showed that aneurysms 
remained stable if the packing density was 30.8±10.2% but 
not if it was 19.9%±10.6%.15 It can therefore be postulated that 
newer coils will produce more stable coiled aneurysms.
Our study, like those of Thornton et al.11 and Batista et al.,7 
found that remnants that were stable at 1 year remained stable. 
It therefore appears that follow-up after 1 year is unnecessary 
in stable coiled aneurysms.
Our thrombo-embolic complication rate was approximately 
5%. Two of these episodes occurred in the course of 
remodelling; however, no patient suffered permanent 
morbidity or mortality as a result.
We did not use the Glasgow Outcome Score or Modified 
Rankin Scale to assess patient outcomes. Instead we 
ascertained whether patients were able to go back to their 
previous occupation, as we believe that neither of the above 
scoring systems is particularly sensitive in assessment of 
patients’ higher mental status. 
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